Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 2,651–2,675 of 27,380 studies, newest first · page 107 of 1096.

November 2025 25

  1. 2025-11-17

    Co‐localization of tau and TDP ‐43 after extracellular vesicle delivery to cells

    ✓ Peer-reviewed Brain tissue and pathology FEBS Journal

    Key finding: Perturbations in the metabolism of microtubule‐associated protein tau (tau) underlie the pathology of a broad array of dementias, including chronic traumatic encephalopathy, amyotrophic lateral sclerosis (ALS) with cognitive impairment (ALSci) and approximately half of the dementias associated with frontotemporal lobar degeneration. +1 more finding

  2. 2025-11-17

    EEG spectral power differences in Alzheimer’s disease and frontotemporal dementia

    ✓ Peer-reviewed Cognitive tests and assessment International Journal of Neuroscience

    Key finding: Both patient groups showed significant deviations from HC, but with distinct patterns. +4 more findings

  3. 2025-11-17

    Measuring Mindfulness: Differences in the 15-Item Five Facet Mindfulness Questionnaire in Black and White Dementia Caregivers

    ✓ Peer-reviewed Disparities Clinical Gerontologist

    Key finding: The FFMQ-15 may reflect different experiences of mindfulness among Black caregivers of PWD. +4 more findings

  4. 2025-11-17

    Explainable Machine Learning-Based Classification of Clinical Dementia Ratings Using a Tablet-Based Cognitive Assessment

    ✓ Peer-reviewed Getting a diagnosis International Journal of Computational Intelligence Systems

    Key finding: Among different ML models, the deep learning model demonstrated superior predictive performance, achieving an accuracy of 100% and 95.8% for training and testing, respectively. +1 more finding

  5. 2025-11-17

    CSF α-Synuclein Seed Amplification Assays and Alzheimer Disease Biomarkers in Dementia With Lewy Bodies: Presentation and Progression

    ✓ Peer-reviewed Tau biomarkers Neurology

    Key finding: α-Synuclein (αSyn) seed amplification assays (SAAs) accurately detect αSyn pathology in dementia with Lewy bodies (DLB). +3 more findings

  6. 2025-11-17

    High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer's disease phenotypes in a large mixed-dementia cohort

    ✓ Peer-reviewed Biomarkers Molecular neurodegeneration

    Key finding: We identified proteins associated with disease status and AD-related phenotypes (Clinical Dementia Rating®, CSF Aβ42/Aβ40, Amyloid-PET, and Tau-PET). +4 more findings

  7. 2025-11-16

    Engineered butyrate-producing yeasts mitigate Alzheimer-associated phenotypes

    ✓ Peer-reviewed Risk genes beyond APOE Signal Transduction and Targeted Therapy

    Key finding: Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease without effective treatments. 1 Extracellular amyloid plaques, neurofibrillary tangles, neuroinflammation, and neuronal loss are the characteristics of AD neuropathology. +3 more findings

  8. 2025-11-15

    Challenging the Wine Component in Mediterranean Diet Scores: Cognitive Outcomes in Portuguese Adults at High Risk of Dementia

    ✓ Peer-reviewed Cognitive tests and assessment Nutrients

    Key finding: MEDAS-R was positively associated with better MMSE performance (p = 0.043) and showed a borderline association with the MoCA (p = 0.051), but not with the ACE-R score (p = 0.356). +4 more findings

  9. 2025-11-15

    Preclinical and Prodromal Frontotemporal Dementia: Challenges and Opportunities

    ✓ Peer-reviewed Lewy body dementia International Journal of Translational Medicine

    Key finding: Increasing evidence indicates that disease mechanisms begin decades before the appearance of clinical symptoms, highlighting the importance of identifying preclinical and prodromal stages.

  10. 2025-11-15

    A modified α-synuclein seed amplification assay in Lewy body dementia using Raman spectroscopy and machine learning analysis

    ✓ Peer-reviewed Digital health tools Journal of Neuroscience Methods

    Key finding: Despite the very limited sample size, these findings highlight the potential of this novel workflow and strongly warrant its validation in larger cohorts.

  11. 2025-11-14
  12. 2025-11-14

    TDP-43 Regulates Rab4 Levels to Support Synaptic Vesicle Recycling and Neuromuscular Connectivity in Drosophila and Human ALS Models

    ✓ Peer-reviewed Brain tissue and pathology International Journal of Molecular Sciences

    Key finding: Together, these findings define a TDP-43/Rab4/futsch/MAP1B regulatory axis that couples endosomal dynamics to cytoskeletal assembly.

  13. 2025-11-14

    Polymer-Engineered Aβ-Degrading Proteases via Photo-ATRP for Alzheimer's Disease Therapeutics

    ✓ Peer-reviewed Drug development Eurasian journal of applied biotechnology

    Key finding: BSA-polymer conjugates displayed enhanced resistance to proteolytic degradation. +4 more findings

  14. 2025-11-14
  15. 2025-11-14

    Mild Cognitive Impairment and Sarcopenia: Effects of Resistance Exercise Training on Neuroinflammation, Cognitive Performance, and Structural Brain Changes

    ✓ Peer-reviewed Mild cognitive impairment International Journal of Molecular Sciences

    Key finding: Clinically, RET has demonstrated significant and sustained improvements in executive function, memory, and global cognition, with effects persisting for up to 18 months.

  16. 2025-11-14

    Predictors of Transition from Mild Cognitive Impairment to Normal Cognition and Dementia

    ✓ Peer-reviewed Disparities Behavioral Sciences

    Key finding: Patients in the rMCI group were significantly younger and had a higher level of education compared with those in the pMCI group. +2 more findings

  17. 2025-11-14

    End-of-Life Care for Older Adults With Dementia by Race and Ethnicity and Physicians’ Role

    ✓ Peer-reviewed Disparities JAMA Health Forum

    Key finding: Among 259 945 decedents with dementia (mean [SD] age, 85.8 [8.0] years; 60.4% female), 8.3% were non-Hispanic Black, 4.4% were Hispanic, and 87.3% were non-Hispanic White. +4 more findings

  18. 2025-11-14

    An Ultra-Brief Informant Questionnaire for Case Finding of Cognitive Impairment Across Diverse Literacy: Diagnostic Accuracy Study

    ✓ Peer-reviewed Getting a diagnosis JMIR Aging

    Key finding: This ultra-brief questionnaire enables rapid screening for cognitive impairment (in <1 min) by family members or as part of community geriatric assessments. +1 more finding

  19. 2025-11-13

    The Multinutrient Fortasyn Connect Influences Gut Microbiota and Intestinal Function in Early Alzheimer's Disease

    ✓ Peer-reviewed Disease mechanisms Aging and disease

    Key finding: In patients, supplementation was associated with higher fecal abundance of Bifidobacterium and Christensenellaceae, reduced inflammatory markers (calprotectin and myeloperoxidase), and increased butyrate levels.

  20. 2025-11-13

    Using retinal diagnostics as a biomarker for neurodegenerative diseases: protocol for a systematic review

    ✓ Peer-reviewed Brain scans and imaging BMJ open

    Key finding: A narrative synthesis approach will be used to analyse the results, with meta-analysis performed if there is sufficient data.

  21. 2025-11-13

    Acupuncture modulates the microbiota-gut-brain axis: a novel therapeutic strategy for amnestic mild cognitive impairment

    ✓ Peer-reviewed Mild cognitive impairment Frontiers in Neuroscience

    Key finding: Amnestic mild cognitive impairment (aMCI) represents a critical prodromal stage of Alzheimer's disease (AD), yet effective therapeutic interventions to prevent or delay this conversion remain an unmet clinical need. +4 more findings

  22. 2025-11-13

    Predictive factors for dementia among older adults in South Korea: an interpretable machine learning analysis

    ✓ Peer-reviewed Digital health tools Alzheimer s Research & Therapy

    Key finding: Predictive performance was comparable across algorithms, with R² ranging from 0.201 to 0.361, highest in the MCI_All dataset. +4 more findings

  23. 2025-11-13
  24. 2025-11-13

    Healthy Brain Healthy Life: an innovative and culturally tailored approach to dementia prevention in minority ethnic communities

    ✓ Peer-reviewed Disparities Research for All

    Key finding: Despite having an increased risk of developing dementia, individuals from minority ethnic communities are largely overlooked by research and dementia services and are less likely to receive timely diagnosis and appropriate support.

  25. 2025-11-13

    Diagnostic Value of Serum p-tau217 in Alzheimer Disease: Equal to Plasma in Levels and Clinical Utility?

    ✓ Peer-reviewed Biomarkers Clinical Chemistry

    Key finding: High correlations between plasma and serum were observed for most assays (ρ > 0.8), though plasma often yielded higher concentrations. +4 more findings

Browse the library by subject, with the full score breakdown →